Accor Partners With x.labs To Offer Covid-19 Testing Solutions Across U.S. & Canada
Accor To Be One Of The First Major Hospitality Companies To Deliver Streamlined Testing Options At All Of Its Managed Properties
World leading augmented hospitality group Accor announced today a partnership with the leader in next-generation digital healthcare technologies x.labs to provide COVID-19 testing options to leisure guests and groups across all Accor-managed hotels in the U.S. and Canada.
PreCheck PCR testing kits will also be available to order directly from x.labs for at-home testing prior to traveling through a special co-branded Accor and x.labs website. Through this site only, testing kits are available at no cost for U.S. residents, through insurance providers and the Families First Coronavirus Response Act, the Health Care Enhancement Act, and the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Meetings & Events
For groups hosting meetings and events at Accor properties, planners will receive special access to a concierge contact at x.labs to coordinate at-home PreCheck diagnostic testing kits and/or on-site COVID-19 antigen rapid testing for attendees.
To organize advance PreCheck PCR testing kits, planners simply place an order with the x.labs concierge and the kits will be sent directly to attendees for at-home testing. Planners can set up parameters for clearance to attend their meeting or event - including a negative PCR test, acceptable temperature range, and customizable wellness and symptom survey - and track results via the PreCheck App prior to the event.
Planners may also order antigen rapid tests directly through the x.labs concierge; however they must arrange for a local medical professional to administer onsite testing. Planners can track test results in real-time via the READY App to see who has been cleared for attendance.
Both PreCheck PCR testing kits and antigen rapid testing kits are available through x.labs at preferred pricing offered exclusively for Accor guests and clients. All x.labs partner products are FDA authorized, as well as all digital data are HIPAA, SOC2 and GDPR compliant. Accor is not involved in the administering of tests.
This announcement is the next step in a series of positive developments including the launch of Accor's ALLSAFE hygiene and cleanliness prevention label and the Group's strategic partnership with AXA which provides free access to telemedicine to guests across the 5,000 Accor hotels worldwide. To learn more about the extensive measures Accor is taking to safeguard, protect and care for its valued guests and employees, visit ALLSafeandWell.com and ALLMeetWell.com.
Accor is a world leading hospitality group consisting of more than 5,000 properties and 10,000 food and beverage venues throughout 110 countries. The group has one of the industry's most diverse and fully-integrated hospitality ecosystems encompassing luxury and premium brands, midscale and economy offerings, unique lifestyle concepts, entertainment and nightlife venues, restaurants and bars, branded private residences, shared accommodation properties, concierge services, co-working spaces and more. Accor also boasts an unrivalled portfolio of distinctive brands and approximately 300,000 team members worldwide. Over 65 million members benefit from the company's comprehensive loyalty program ALL - Accor Live Limitless - a daily lifestyle companion that provides access to a wide variety of rewards, services and experiences. Through its Planet 21 - Acting Here, Accor Solidarity, RiiSE and ALL Heartist Fund initiatives, the group is focused on driving positive action through business ethics, responsible tourism, environmental sustainability, community engagement, diversity and inclusivity. Founded in 1967, Accor SA is headquartered in France and publicly listed on the Euronext Paris Stock Exchange (ISIN code: FR0000120404) and on the OTC Market (Ticker: ACRFY) in the United States. For more information visit group.accor.com or follow Accor on Twitter and Facebook.